Representative(s) Michelle Martin, RN, BSN Chris Calhoun Michelle Hirschtritt Theresa Bui, Pharm. D., MBA | Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website: the tps://www.exelixis.com | Virtual Drop In:March 6th |